2012/07/03, 04:34 PM
سروش جان امروز خیلی تو سایت FDA سرچ کردم این دارو سال 2001 برای بیماری سرطان تاییدیه گرفته و هنوز تاییدیه ام اس نداره مطمئنا اینو برات شیفت نمیدن من امیدوارم که با پالس حمله سرکوب بشه و همون ربیف رو استفاده کنی
Proper name: Alemtuzumab
Tradename: Campath
Manufacturer: Millennium and ILEX Partners, LP, Cambridge, MA , License #1289
Indication for Use: Treatment of patients with B-cell chronic lymphocytic leukemia who have been treated with alkylating agents and who have failed fludarabine therapy
Approval Date: 5/7/2001
Type of submission: Biologics license application
Proper name: Alemtuzumab
Tradename: Campath
Manufacturer: Millennium and ILEX Partners, LP, Cambridge, MA , License #1289
Indication for Use: Treatment of patients with B-cell chronic lymphocytic leukemia who have been treated with alkylating agents and who have failed fludarabine therapy
Approval Date: 5/7/2001
Type of submission: Biologics license application
